Celularity Analyst Ratings
Celularity Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/23/2022 | 114.29% | Truist Securities | $10 → $6 | Maintains | Hold |
| 06/22/2022 | 435.71% | HC Wainwright & Co. | → $15 | Initiates Coverage On | → Buy |
| 04/06/2022 | — | Truist Securities | Downgrades | Buy → Hold | |
| 01/28/2022 | 221.43% | Oppenheimer | → $9 | Initiates Coverage On | → Outperform |
| 11/24/2021 | 221.43% | Morgan Stanley | → $9 | Initiates Coverage On | → Equal-Weight |
| 10/19/2021 | 328.57% | Truist Securities | → $12 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 2022 年 8 月 23 日 | 114.29% | Truist 證券 | 10 美元 → 6 美元 | 維護 | 保持 |
| 06/22/2022 | 435.71% | HC Wainwright & Co. | → 15 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 04/06/2022 | — | Truist 證券 | 降級 | 買入 → 持有 | |
| 01/28/2022 | 221.43% | 奧本海默 | → 9 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
| 11/24/2021 | 221.43% | 摩根士丹利 | → 9 美元 | 啓動覆蓋範圍開啓 | → 重量相等 |
| 10/19/2021 | 328.57% | Truist 證券 | → 12 美元 | 啓動覆蓋範圍開啓 | → 購買 |
Celularity Questions & Answers
Cellarity 問題與解答
The latest price target for Celularity (NASDAQ: CELU) was reported by Truist Securities on August 23, 2022. The analyst firm set a price target for $6.00 expecting CELU to rise to within 12 months (a possible 114.29% upside). 6 analyst firms have reported ratings in the last year.
Truist Securities於2022年8月23日公佈了Celularity（納斯達克股票代碼：CELU）的最新目標股價。該分析公司將目標股價定爲6.00美元，預計CELU將在12個月內升至12個月內（可能上漲114.29％）。去年有6家分析公司公佈了評級。
The latest analyst rating for Celularity (NASDAQ: CELU) was provided by Truist Securities, and Celularity maintained their hold rating.
Truist Securities對Celularity（納斯達克股票代碼：CELU）的最新分析師評級由Truist Securities提供，Celularity維持其持有評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Celularity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Celularity was filed on August 23, 2022 so you should expect the next rating to be made available sometime around August 23, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Celularity的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Celularity的最新評級是在2022年8月23日發佈的，因此您應該預計下一個評級將在2023年8月23日左右公佈。
While ratings are subjective and will change, the latest Celularity (CELU) rating was a maintained with a price target of $10.00 to $6.00. The current price Celularity (CELU) is trading at is $2.80, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Celularity（CELU）評級保持不變，目標股價爲10.00美元至6.00美元。Celularity（CELU）目前的交易價格爲2.80美元，超出了分析師的預期區間。